Clinical Microbiology and Infection

CMI is a monthly peer-reviewed medical journal publishing applied and basic research in the field of #clinicalmicrobiology and #infectiousdiseases

[Clinical Microbiology and Infection @CMIJournal]

October 2026 Issue is now online: https://t.co/ddDit9yEAS

[Clinical Microbiology and Infection @CMIJournal]

This article investigates the clinical characteristics and outcomes of patients with early vs. late diagnosis of infectious encephalitis in Denmark: https://t.co/AcnIyMgJDT

[Clinical Microbiology and Infection @CMIJournal]

In honor of #PeerReviewWeek we would like to thank our peer reviewers for their important and insightful contributions to CMI. We deeply value the time, effort and expertise that goes into writing each peer-review.

[Clinical Microbiology and Infection @CMIJournal]

Development of new antifungal agents is challenging because of limited target sites, emergence of resistance, and adverse toxicity profiles. New agents offer alternative options for difficult-to-treat infections: https://t.co/RMvzTof4vs

[Clinical Microbiology and Infection @CMIJournal]

📣 In the September 2026 issue: Andes virus–associated cardiopulmonary syndrome: diagnostic approaches, clinical management, and evidence gaps—a scoping review
https://t.co/1HQadlgf0P

[Clinical Microbiology and Infection @CMIJournal]

September 2026 Issue is now online: https://t.co/zY2FvC1Qbz

[Clinical Microbiology and Infection @CMIJournal]

Community-acquired pneumonia (CAP) is a leading cause of healthcare visits. This study aims to examine the effectiveness of doxycycline for outpatient CAP compared with other antibiotics:
https://t.co/j9u4jG0D9f

[Clinical Microbiology and Infection @CMIJournal]

A systematic review and meta-analysis evaluating the impact of nudging in microbiology reports on antimicrobial use and clinical outcomes:
https://t.co/gNLUCDK38k

[Clinical Microbiology and Infection @CMIJournal]

Strengthen your clinical research skills at this onsite course. Explore study design, bias reduction, scientific writing, and the latest developments in clinical trial methodology through practical, project-based learning.

Learn more & sign up today! https://t.co/NyxkessrxX

[S.Enf.Infecciosas HRUM @infeccHRUmalaga]

En @CMIJournal con participación de nuestro centro #JDRuizMesa. 1465 pacientes, Multicentrico, Retrospectivo en 🇪🇸 con #propensivo💻➡️#FIDAXOMICINA en administración CONVENCIONAL 🆚 “TAPERING👉🏻MISMA recurrencia 🟰🔄 en este estudio en vida real💩🏥🏡
🔗🆓https://t.co/aBKu9Odz2V

[Clinical Microbiology and Infection @CMIJournal]

Enterococcus faecalis is a challenging cause of endocarditis and often occurs in elderly, frail patients. The aim of this study was to evaluate the use of moxifloxacin for treating E. faecalis endocarditis: https://t.co/8fOh10acTg

[Clinical Microbiology and Infection @CMIJournal]

This prospective, population-based study examines the incidence, clinical presentation, and prognosis of infectious encephalitis among adults in Denmark: https://t.co/Z6tiQrrDmG

[Clinical Microbiology and Infection @CMIJournal]

This review explores why MICs can vary between methods, highlights key sources of testing discordance, and discusses clinically important phenomena such as tolerance and heteroresistance that standard MIC testing may miss:
https://t.co/xCVw3EobI8

[Clinical Microbiology and Infection @CMIJournal]

August 2026 Issue is now online: https://t.co/4UVPJOqAci

[Clinical Microbiology and Infection @CMIJournal]

New original article demonstrates that DENOVA supports risk stratification for IE in patients with EfB, informing clinical decision-making and use of transoesophageal echocardiography.
Read the full article: https://t.co/49wRADpNrr

[Clinical Microbiology and Infection @CMIJournal]

📣 In the July 2026 issue: Association between early SARS-CoV-2 viral rebound and post-COVID conditions among immunocompromised patients: cohort study
https://t.co/97RD24vUNs

#covid #IDtwitter

[Mireia Bernabéu-Gimeno @mire_bg]

Excited to share our new Letter in @CMIJournal, where we explored the extent of anti-phage immunity induced by phage therapy! 🧫🔬 https://t.co/N68YKrFCpx 1/4

[Clinical Microbiology and Infection @CMIJournal]

📣 New Supplement publication in CMI

The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the #EUCAST Subcommittee @ESCMID

Read here: https://t.co/ZrtZmncTwy

[Clinical Microbiology and Infection @CMIJournal]

🌟 The 2025 JCR Impact Factor for CMI has risen to 8.7!

We thank our editors, reviewers, authors and readers for their dedication and extraordinary work.

Read about how CMI did in 2025 here: https://t.co/13O0OXuucM

#IDTwitter #Microbiology #InfectiousDiseases #JIF #JCR2025

[Clinical Microbiology and Infection @CMIJournal]

📣 Deadline for the open call to join the CMI editorial board as an editor in virology is July 31st!

Learn more about the qualifications and expectations of the role, and how to apply in the editorial note: https://t.co/z2Vn5lGws4